Skip to main content

Valerie Nicholson, an Indigenous women living with HIV and chair of the board for the Canadian Aboriginal AIDS Network, says she has no shortage of stories about the racism she and others have experienced while accessing care.

Rafal Gerszak/The Globe and Mail

Indigenous women living with HIV experience everyday incidents of racism that impede their access to care disproportionately to other groups, according to a study involving more than 1,400 women across Canada.

This contributes to a loss of Indigenous women along the HIV “cascade of care” – a term used to describe clinical stages of treatment such as diagnosis, retention in care and viral suppression – at a markedly higher rate than other than other ethnicities (-25 per cent compared with -15 per cent to -16 per cent).

“One of the things that came out, quite fascinatingly, in our study was that Indigenous women did have higher attrition rates,” said Angela Kaida, an associate researcher at the BC Centre for Excellence in HIV/AIDS (BC-CfE), an associate professor at Simon Fraser University (SFU) and senior author of the study.

Story continues below advertisement

“But when we factored in experiences of racism – not [ethnicity itself] but how much racism you’re encountering in your everyday life – that’s really what was causing the effect.”

Examples include prejudiced comments from health-care providers and disrespect for cultural traditions.

The study’s finding highlights the need for more Indigenous peers in the planning and delivery of such HIV care as well as culturally relevant services in general for Canada’s Indigenous people, Dr. Kaida said.

The study was published this week in the Journal of Acquired Immune Deficiency Syndromes and includes research from the BC-CfE, SFU and the BC Women’s Hospital.

Of 1,424 women living with HIV involved in the study, 98 per cent had started receiving HIV care, 97 per cent of those received care in the past year and 89 per cent initiated anti-retroviral therapy. Among those who initiated the treatment, 94 per cent remained on it.

Among participants who are currently on anti-retrovirals, 83 per cent were adherent and 87 per cent maintained viral suppression, which stunts the development of AIDS and reduces the risk of HIV transmission by more than 95 per cent.

The study found that African, Caribbean or black women had the highest prevalence of viral suppression (84 per cent) while Indigenous women had the lowest (57 per cent).

Story continues below advertisement

Valerie Nicholson is chair of the board of directors for the Canadian Aboriginal AIDS Network, an Indigenous peer navigator with the advocacy group Positive Living BC and a peer research associate with the Canadian HIV Sexual and Reproductive Health Cohort Study, which includes 1,424 women living with HIV. She is also an Indigenous woman living with the virus herself.

In these roles, she has no shortage of stories about racism and other cultural insensitivities she and others experience on a regular basis while accessing care.

There was the time she gave a bedridden Indigenous youth an eagle feather – highly revered and considered sacred – to find later that hospital staff had stuffed it in a drawer. In another incident, the health-care provider assumed Ms. Nicholson herself must have substance-use issues: “Well, you’re an Indian, aren’t you?”

Another time, a woman recently diagnosed with HIV visited a physician who asked: “How many people have you infected? One dozen? Two dozen? More?”

“He said that because she’s an Indigenous woman,” Ms. Nicholson said. “Why would she go back after that?”

At Positive Living BC, Ms. Nicholson incorporates Indigenous traditions such as tobacco offerings, cedar brushings and smudging to purify the body and space before talking about medications and other Western treatment.

Story continues below advertisement

“When I use this approach, women adhere to medications at a better rate than ones who haven’t connected back to spirit,” she said.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter